1. Home
  2. ALDX vs SPCE Comparison

ALDX vs SPCE Comparison

Compare ALDX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • SPCE
  • Stock Information
  • Founded
  • ALDX 2004
  • SPCE 2017
  • Country
  • ALDX United States
  • SPCE United States
  • Employees
  • ALDX N/A
  • SPCE N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • SPCE Transportation Services
  • Sector
  • ALDX Health Care
  • SPCE Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • SPCE Nasdaq
  • Market Cap
  • ALDX 133.7M
  • SPCE 125.3M
  • IPO Year
  • ALDX 2014
  • SPCE N/A
  • Fundamental
  • Price
  • ALDX $2.17
  • SPCE $3.13
  • Analyst Decision
  • ALDX Strong Buy
  • SPCE Hold
  • Analyst Count
  • ALDX 2
  • SPCE 4
  • Target Price
  • ALDX $9.50
  • SPCE $13.06
  • AVG Volume (30 Days)
  • ALDX 1.2M
  • SPCE 10.0M
  • Earning Date
  • ALDX 05-14-2025
  • SPCE 05-15-2025
  • Dividend Yield
  • ALDX N/A
  • SPCE N/A
  • EPS Growth
  • ALDX N/A
  • SPCE N/A
  • EPS
  • ALDX N/A
  • SPCE N/A
  • Revenue
  • ALDX N/A
  • SPCE $5,512,000.00
  • Revenue This Year
  • ALDX N/A
  • SPCE N/A
  • Revenue Next Year
  • ALDX N/A
  • SPCE $5,510.36
  • P/E Ratio
  • ALDX N/A
  • SPCE N/A
  • Revenue Growth
  • ALDX N/A
  • SPCE N/A
  • 52 Week Low
  • ALDX $1.14
  • SPCE $2.18
  • 52 Week High
  • ALDX $7.20
  • SPCE $19.54
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 38.93
  • SPCE 44.72
  • Support Level
  • ALDX $2.10
  • SPCE $3.64
  • Resistance Level
  • ALDX $2.30
  • SPCE $3.93
  • Average True Range (ATR)
  • ALDX 0.15
  • SPCE 0.58
  • MACD
  • ALDX 0.06
  • SPCE -0.08
  • Stochastic Oscillator
  • ALDX 37.93
  • SPCE 0.28

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Share on Social Networks: